Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.
Poynard T, Munteanu M, Charlotte F, Perazzo H, Ngo Y, Deckmyn O, Pais R, Merrouche W, de Ledinghen V, Mathurin P, Ratziu V; FLIP Consortium, the FibroFrance-CPAM Group, the FibroFrance-Obese Group. Poynard T, et al. Among authors: merrouche w. Eur J Gastroenterol Hepatol. 2018 May;30(5):569-577. doi: 10.1097/MEG.0000000000001064. Eur J Gastroenterol Hepatol. 2018. PMID: 29406435
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, Colombo M, Thibault V, Schiff E, Brass CA, Albrecht JK, Rudler M, Deckmyn O, Lebray P, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group; Epic3 Study Group; Bordeaux HCV Study Group. Poynard T, et al. Among authors: merrouche w. J Hepatol. 2014 Apr;60(4):706-14. doi: 10.1016/j.jhep.2013.11.016. Epub 2013 Nov 26. J Hepatol. 2014. PMID: 24291240
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
Poynard T, Vergniol J, Ngo Y, Foucher J, Thibault V, Munteanu M, Merrouche W, Lebray P, Rudler M, Deckmyn O, Perazzo H, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group and the Bordeaux HBV Study Group. Poynard T, et al. Among authors: merrouche w. J Hepatol. 2014 Nov;61(5):994-1003. doi: 10.1016/j.jhep.2014.06.027. Epub 2014 Jul 10. J Hepatol. 2014. PMID: 25016224
Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Castéra L, et al. Among authors: merrouche w. J Hepatol. 2009 Jan;50(1):59-68. doi: 10.1016/j.jhep.2008.08.018. Epub 2008 Oct 26. J Hepatol. 2009. PMID: 19013661
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Marra F, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Barbara M, Le-Bail B, Arena U, Craxì A, de Ledinghen V. Petta S, et al. Among authors: merrouche w. Hepatology. 2017 Apr;65(4):1145-1155. doi: 10.1002/hep.28843. Epub 2016 Nov 5. Hepatology. 2017. PMID: 27639088
38 results